Shire (SHP)

Share price graph

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 4347.50p Today's change: -0.80%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 4347.50p 5 day change: -1.28%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 4347.50p 6 month change: +27.99%

Contact details

Address: 22 Grenville Street, St Helier, Jersey
Phone: +44 (0) 1256 894 000
Fax: +44 (0) 1256 894 708
Website: www.shire.com

Company information

Drugs group Shire Pharmaceuticals is best known for the attention deficit disorder treatments Adderall and Vyvanse. Founded in 1986 and became a listed company in 1996.

Linklaters has fallen to the bottom of the pile in terms of magic circle partner profits after profit per equity [...]

12 July 2018
Shares
1
Views
429

Japanese drugmaker Takeda said today that it had received US regulatory approval for its planned $62bn (£47bn) [...]

10 July 2018
Shares
1
Views
159

Shire’s share price rose by more than two per cent this morning following the defeat today of a group of rebel [...]

28 June 2018
Shares
2
Views
635

A group of Takeda shareholders is working to block the $62bn (£46.4bn) acquisition of Shire, news agency Reuters [...]

11 June 2018
Shares
1
Views
375

Japanese pharmaceutical giant Takeda announced today that entered into a $7.5bn (£5.6bn) term loan credit agreement [...]

8 June 2018
Views
567

Takeda's £46bn takeover of London-listed Shire "carries overly high risk", a bloc of investors in the Japanese [...]

29 May 2018
Shares
1
Views
1,056

Worldwide deal making passed $2 trillion (£1.49 trillion) yesterday, pushing on from the all-time high set at [...]

22 May 2018
Shares
1
Views
1,425

The haemophilia treatment drug Hemlibra is set to take up a dominant position on the market as it dramatically [...]

21 May 2018
Views
148

What links Paul Walsh, Sir Nigel Rudd and Vagn Sorensen? Other than chairing three of the London market’s blue-chip [...]

18 May 2018
Shares
1
Views
557

The FTSE has continued to rally this morning, buoyed by a strong performance on Wall Street overnight and positive [...]

8 May 2018
Views
164

Shire shareholders are witnessing billions of pounds being wiped off the value of a takeover by Japanese pharmaceutical [...]

25 April 2018
Shares
4
Views
646

Investors are quite rightly concerned over debt-fuelled acquisitions, as history is littered with companies that [...]

25 April 2018
Views
275

Japanese pharmaceuticals giant Takeda today made a fresh approach for London-listed rival Shire, with a deadline [...]

24 April 2018
Shares
2
Views
728

The FTSE 100 has continued the slow climb it began at the beginning of this week, closing today at 7,361.56 [...]

20 April 2018
Views
186

A bidding war is on the cards for Ireland-based pharmaceuticals giant Shire as Botox maker Allergan wades into [...]

19 April 2018
Views
157

Content tagged with "Shire"